Fibrocell files IND for gene therapy to treat scleroderma; shares up 2%Seeking AlphaFibrocell Science (FCSC +2%) has submitted an Investigational New Drug (IND) application to the FDA seeking approval to launch a clinical trial evaluating gene therapy … Continue reading
Muscular Dystrophy NewsResearchers Use Artificial Chromosomes to Deliver Gene Therapy for DMDMuscular Dystrophy NewsEffective gene therapies for Duchenne MD face two major obstacles. One is that the dystrophin gene is large, so finding a way to deliver… Continue reading
KSAT San Antonio |
Dual Immunotherapy Eliminates Tumors in Animal Cancer Models
Sci-News.com Injecting amounts of two immune-stimulating agents directly into tumors in multiple types of mouse cancer models can eliminate all traces of cancer, according to a new study published in the journal Science Translational Medicine. Dual immunotherapy … ‘Miraculous’ new cancer vaccine completely wipes out tumorsMother Nature Network United States researchers develop immunity injections against cancerNewburgh Gazette Cancer breakthrough: Vaccine cures mice in studyNew Zealand Herald Health Thoroughfare –MilTech –Brinkwire (press release) all 34 news articles » |
STAT |
Bristol claims victory in crucial immunotherapy trial, but results raise some questions
STAT ristol-Myers Squibb reported positive results Monday in a crucial immunotherapy trial, using a combination of the two drugs Opdivo and Yervoy to treat patients with a specific type of non-small cell lung cancer patients. The outcome of the study known … Bristol-Myers says a key trial for its lung cancer drug succeedsCNBC Bristol-Myers’ lung cancer drug succeeds key trial; shares riseReuters UPDATED: Bristol-Myers scores big, wows checkpoint field with an early hit on Opdivo-Yervoy combo for lung cancerEndpoints News The Pharma Letter –USA TODAY all 143 news articles » |
Wisconsin Public Radio News |
Emerging Cancer Therapies Rely On Patient’s Immune System
Wisconsin Public Radio News One way to fight cancer is by harnessing the patient’s own immune system to attack tumors. Medical researchers in Milwaukee are testing this emerging therapy, but with a twist. In recent years, there’s been dramatic progress using a patients’ own … |